ResMed | RMD - Trade Creditors


ResMed reported $308.92M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Ansell USD 302.3M 51.4M Dec/2025
Artivion USD 20.87M 2.53M Jun/2026
AtriCure USD 78.74M 8.68M Jun/2026
Baxter International USD 1.03B 52M Jun/2026
Cochlear AUD 281.3M 17.1M Dec/2025
Cooper Companies USD 251.2M 17.9M Jun/2026
CSL USD 3.17B 290M Dec/2025
Dexcom USD 2.08B 134.8M Jun/2026
Edwards Lifesciences USD 210.5M 29.4M Jun/2026
Fisher Paykel Healthcare NZD 300.1M 32.3M Jun/2026
Globus Medical USD 106.94M 3.28M Jun/2026
Haemonetics USD 56.34M 5.28M Jun/2026
Idexx Laboratories USD 129.1M 877K Jun/2026
Inogen USD 21.22M 684K Sep/2025
Insulet USD 123.3M 26.5M Jun/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
Intuitive Surgical USD 1.92B 66.6M Jun/2026
Medtronic USD 2.7B 51M Jun/2026
Philips EUR 2.08B 90M Jun/2026
Ramsay Health Care AUD 2.02B 289.9M Dec/2025
ResMed USD 308.92M 35.62M Jun/2026
Sigma Healthcare AUD 1.32B 970.03M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Steris USD 344.1M 5.3M Jun/2026
Teleflex USD 143.29M 335K Jun/2026
Thermo Fisher Scientific USD 3.34B 278M Mar/2026